−250 KRW
−17.24 B KRW
3.71 B KRW
29.98 M
About KOLON TISSUEGENE, INC.
Sector
Industry
CEO
Moon-Jong Noh
Website
Headquarters
Rockville
Founded
1999
ISIN
KR8840120008
FIGI
BBG00HNRMTN4
Kolon TissueGene, Inc. is a biopharmaceutical company, which engages in the development of clinical-stage cell therapies for osteoarthritis. It offers TG-C, a platform technology that consists of a combination of allogeneic primary cells combined with genetically modified cells. The company was founded by Kwan H. Lee on June 9, 1999 and is headquartered in Rockville, MD.
Displays a symbol's price movements over previous years to identify recurring trends.